-
CTN-0015: Preliminary findings from the “Women and Trauma” study.
Hien DA. CTN 0015: Preliminary findings from the "Women and Trauma" study. Presented at the American Academy of Addiction Psychiatry Annual Meeting and Symposium, St. Petersburg, FL, December 7-10, 2006.
-
Integrated treatment for trauma and addiction: Seeking Safety.
Hien DA, Simpson T. Integrated treatment for trauma and addiction: Seeking Safety. Presented at the NIDA Blending Conference, "Blending Addiction Science & Practice: Bridges to the Future," Seattle, WA, October 16-17, 2006.
-
Treatment program perspective: Conducting research in the NIDA Clinical Trials Network.
Song YS. Treatment program perspective: Conducting research in the NIDA Clinical Trials Network. Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006.
-
Abstinence incentive effects in psychosocial counseling patients testing stimulant positive vs. negative at treatment entry.
Stitzer ML. Abstinence incentive effects in psychosocial counseling patients testing stimulant positive vs. negative at treatment entry. Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006.
-
HCV-related services in substance abuse treatment settings: The NIDA Clinical Trials Network.
Brown LS Jr. HCV-related services in substance abuse treatment settings: The NIDA Clinical Trials Network. Presented at the American Association for the Treatment of Opioid Dependence (AATOD) annual meeting, 2006.
-
HIV/AIDS-related services in substance abuse treatment settings: Preliminary results.
Brown LS Jr. HIV/AIDS-related services in substance abuse treatment settings: Preliminary results. The NIDA Clinical Trials Network. Presented at the College on Problems of Drug Dependence annual meeting, June 17-22, 2006.
-
Relationships between the availability of infection-related services & availability of services tailored for subpopulations in substance abuse treatment programs : The NIDA Clinical Trials Network.
Brown LS Jr. Relationships between the availability of infection-related services & availability of services tailored for subpopulations in substance abuse treatment programs : The NIDA Clinical Trials Network. Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006.
-
Study design for a randomized controlled trial of osmotic-release methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in adolescents with substance use disorders.
Winhusen TJ. Study design for a randomized controlled trial of osmotic-release methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in adolescents with substance use disorders. Presented at the New Clinical Drug Evaluation Unit (NCDEU) annual meeting, June 12-15, 2006.
-
Using buprenorphine in opioid treatment programs.
Cohen AJ. Using buprenorphine in opioid treatment programs. Presented at the American Association for the Treatment of Opioid Dependence (AATOD) annual meeting, Atlanta, GA, April 2006.
-
HIV and HCV risk reduction interventions in drug detoxification and treatment settings.
Booth RE. HIV and HCV risk reduction interventions in drug detoxification and treatment settings. Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006.